APT Medical Inc (SHG:688617) — Market Cap & Net Worth
Market Cap & Net Worth: APT Medical Inc (688617)
APT Medical Inc (SHG:688617) has a market capitalization of $5.04 Billion (CN¥34.45 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #3571 globally and #496 in its home market, demonstrating a -1.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying APT Medical Inc's stock price CN¥243.42 by its total outstanding shares 141529162 (141.53 Million). Also see 688617 total assets for a full breakdown of the balance sheet.
APT Medical Inc Market Cap History: 2021 to 2026
APT Medical Inc's market capitalization history from 2021 to 2026. Data shows growth from $3.94 Billion to $5.04 Billion (6.04% CAGR). Also see 688617 operating cash flow for how efficiently the company converts equity into cash flow.
APT Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how APT Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 688617 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.95x
APT Medical Inc's market cap is 1.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.14x
APT Medical Inc's market cap is 6.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.94 Billion | $828.69 Million | $207.92 Million | 4.75x | 18.93x |
| 2022 | $4.34 Billion | $1.22 Billion | $358.02 Million | 3.57x | 12.12x |
| 2023 | $5.51 Billion | $1.65 Billion | $533.92 Million | 3.34x | 10.33x |
| 2024 | $7.71 Billion | $2.07 Billion | $673.15 Million | 3.73x | 11.46x |
| 2025 | $5.04 Billion | $2.58 Billion | $820.64 Million | 1.95x | 6.14x |
Competitor Companies of 688617 by Market Capitalization
Companies near APT Medical Inc in the global market cap rankings as of September 24, 2026. Review APT Medical Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to APT Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
APT Medical Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, APT Medical Inc's market cap moved from $3.94 Billion to $ 5.04 Billion, with a yearly change of 6.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥5.04 Billion | +0.06% |
| 2025 | CN¥5.04 Billion | -34.66% |
| 2024 | CN¥7.71 Billion | +39.82% |
| 2023 | CN¥5.51 Billion | +27.12% |
| 2022 | CN¥4.34 Billion | +10.23% |
| 2021 | CN¥3.94 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of APT Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.04 Billion USD |
| MoneyControl | $5.04 Billion USD |
| MarketWatch | $5.04 Billion USD |
| marketcap.company | $5.04 Billion USD |
| Reuters | $5.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more